Uncategorised - European Medical Journal

Bridging the Gap Between AI Research and Immunology

Discover a study exploring how AI can transform allergy and immunology, highlighting challenges, opportunities, and a roadmap for clinical impact.

Demand for Rheumatology Advice Lines Outpaces Resources

A new survey highlights that patients with rheumatoid arthritis want faster and more personal access to rheumatology telephone advice lines, underscoring the growing strain on these services.

Emotional Support Fuels Growth in Skin Disorders

Patients with psychophysiological skin disorders such as atopic dermatitis, psoriasis, pruritus, and alopecia experience measurable benefits in post-traumatic growth when they receive emotional and informational support, according to new research.

Immune Genes Driving MAFLD Progression and Diagnosis Revealed

Emerging evidence points to the role of CD4+ T cell subsets in fuelling MAFLD-related inflammation and fibrosis.

LSD-Based Treatment Achieves Rapid Anxiety Relief in Clinical Trial

Single-dose MM120 provides fast, lasting anxiety relief in generalised anxiety disorder, paving the way for new treatments.

Coins falling

ABPI report highlights decline in UK pharma investment

The latest ABPI and PwC Pharmaceutical Competitiveness Framework reveals the UK is losing ground in pharma R&D, investment, and clinical trials, with rankings slipping sharply since 2018.

Konstanze Döhner, President Elect, European Hematology Association (EHA); Department of Internal Medicine III, University Hospital of Ulm, Germany.

EHA Interview 2025: Konstanze Döhner

EMJ spoke with Konstanze Döhner, President Elect of the European Hematology Association, about her priorities for the future of haematology, challenges in research and patient care, and the vision behind the EHA2025 theme “Borderless Hematology”.

Three-Month Clofazimine Regimen Fails to Shorten Tuberculosis Treatment

A 3-month clofazimine- and rifapentine-containing regimen for drug-susceptible TB failed to improve cure rates and caused more severe adverse events than standard therapy, according to the Clo-Fast trial.

Martin Dreyling, Professor of Medicine and Head of the Lymphoma Programme, Ludwig Maximilian University, Germany; Scientific Program Committee Chair EHA2025 European Hematology Association (EHA)

EHA Interview 2025: Martin Dreyling

EMJ spoke with Martin Dreyling, Chair of the EHA2025 Scientific Program Committee, about his career journey, what attendees can expect from the upcoming congress, and the vision behind its programme.

Combined Tofacitinib and UVB Therapy Shows Promise in Vitiligo

Ultraviolet B (UVB) phototherapy is the traditional non-pharmacological approach, promoting repigmentation by stimulating melanin production.